Global biomaterial tester demand is anticipated to be valued at US$ 1.25 Billion in 2022, forecast to grow at a CAGR of 4% to be valued at US$ 1.85 Billion from 2022 to 2032.
The growing demand for biomaterial from the healthcare sector is fuelling the global biomaterial tester market. The biomaterial is synthetic or of natural origin which is used for implant repair or replacing missing tissue. With the growing healthcare technology, biomaterial testers have a large application in testing biopolymer and biomaterial.
| Report Attribute | Details |
| Estimated Base Year Value (2021) | US$ 1 Billion |
| Expected Market Value (2022) | US$ 1.25 Billion |
| Anticipated Forecast Value (2032) | US$ 1.85 Billion |
| Projected Growth Rate (2022-2032) | 4% CAGR |
Biomaterial tester helps to meet safety and effectiveness during transplantation. Various key regulations for the use of biomaterial also plays a key role in the demand for biomaterial testers.
Biomaterial tester is used to understand various aspects related to product safety, performance criteria, the tendency for releasing leachable substances, mechanical properties, and others. Biomaterial tester is equipped with a wide range of analytical capabilities to analyse purity, identity, biosafety, and others of biomaterial used in healthcare products.
Biomaterial tester performs various task to analyze biomaterial features such as bioanalysis to support clinical and preclinical trails; process residual quantification such as surfactants and antibiotics; determination of biological species such as DNA, protein content, glycosaminoglycan; ICH stability studies; trace metals; elemental analysis; mechanical testing; and others.
Biometric tester market is primarily driven by various testing standards for compression, tension, torsion, bend, fatigue testing, planar biaxial, static, and axial torsion. Commonly followed testing standards considered by biomaterial tester are:
All these standards and regulations are expected to have a positive impact on the growth of the global biomaterial tester market. Several developments in biomaterial testers with reference to technology are expected to drive the growth of the global biomaterial tester market during the forecast period.
The increasing regulations for use and test for biomaterial are fuelling the demand for biomaterial testers. The significant technological advancements in the healthcare sector are witnessing a potential demand for biomaterial testers.
The challenges hindering the growth of the biomaterial tester market are it requires high maintenance and proper environment to avoid the growth of bacteria. However, vendors for biomaterial testers are offering various training services to clients for maintenance of biomaterial testers and are expected to overcome this challenge during the end of the forecast period.
Asia Pacific is anticipated to capture substantial market shares in the global biomaterial tester market, owing to the factors such as the increasing number of cardiovascular treatment, orthopaedic treatment, dental treatment, and others.
The developing countries of APEJ such as China and India are expected to project high Y-o-Y during the forecast period due to the increasing number of dental implants, orthopaedic surgery, and other treatments.
According to Future Market Insights, North America and Japan are expected to have the prominent market share of the global biomaterial tester market during the forecast period. The continuous innovation in biomaterial and use of advanced technologies is creating a huge demand for biomaterial testers in the U.S. and Japan.
Currently, the market is considerably competitive, with continuous product and technology developments by established as well as new players. Some of the key players in the biomaterial tester market are ADMET, Inc., MTS Systems Corporation, ZwickRoell, Rheolution Inc., CellScale, Intertek Group plc, Applied Test Systems, Presto Group, TestResources, Hillsborough, and others.
Attributed to the presence of such a high number of participants, the market is highly competitive. A biomaterial tester market report also contains projections using a suitable set of assumptions and methodologies. Global biomaterial tester research report provides analysis and information according to market segments such as geographies, application, and industry. Globally, the biomaterial tester market is expected to be fragmented in nature owing to the presence of a large number of players in the local as well as global market.
| Report Attribute | Details |
| Growth Rate | CAGR of 4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global biomaterial tester market to expand at a 4% value CAGR by 2032
North America is expected to be the most opportunistic biomaterial tester market.
ADMET, Inc, MTS Systems Corporation, and ZwickRoell, are some prominent biomaterial tester manufacturers.
Explore Similar Insights
Biomaterial Tester Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
